In this volume an international group of clinicians, researchers and teachers offer an overview of the etiology and management of tardive dyskinesia in the chronically mentally ill which has become a growing problem in the last thirty years. The authors address relevant social issues, such as the ways in which the attitudes and biased opinions of health professionals and the lay public may interfere with neuroleptic dose reduction or discontinuation, and the rise in litigation.
Sprache
Verlagsort
Verlagsgruppe
American Psychiatric Association Publishing
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Illustrationen
18 tables, 22 line diagrams
Maße
Höhe: 228 mm
Breite: 152 mm
Gewicht
ISBN-13
978-0-88048-176-2 (9780880481762)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
The dopaminergic supersensitivity theory; muscarinic receptor heterogeneity; the GABA theory; neuroendocrine and cerebrospinal measurements; abnormal involuntary movements and psychosis; tardive dyskinesia - clinical features; clinical changes during long-term follow-up; contrasts between patients' characteristics; tardive dyskinesia in a psychogeriatric population; tardive dyskinesia in special populations; tardive dystonia - diagnosis and treatment; structural changes in the brain; neuroendocrine aspects of tardive dyskinesia; pathophysiology and therapy of tardive dyskinesia; calcium channel antagonists; the on-off dyskinesia syndrome; novel atypical antipsychotic compounds; legal liability for tardive dyskinesia; a tardive dyskinesia management program.
